New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareGHK-Cu vs Adamax

GHK-Cu vs Adamax

Side-by-side comparison of key properties, dosing, and research.

Skin & CosmeticRecovery & RepairAnti-Aging & Longevity
GHK-Cu
Cognitive Enhancement
Adamax
Summary
GHK-Cu is a naturally occurring copper complex that declines with age. It is one of the most studied anti-aging peptides, known for powerful skin rejuvenation, wound healing, and tissue remodeling effects.
Adamax is a synthetic neuropeptide related to brain-derived neurotrophic factor (BDNF) signaling pathways. It is explored for cognitive enhancement, neuroprotection, and mood support, with proposed mechanisms involving TrkB receptor activation and enhancement of neuroplasticity similar to endogenous BDNF.
Half-Life
2–4 hours
Estimated 1-3 hours (short; peptide degradation)
Admin Route
SubQ, Topical
Subcutaneous, Intranasal (research)
Research
Typical Dose
1–3 mg
200-400 mcg per dose
Frequency
3–5 times per week
Once daily or every other day
Key Benefits
  • Reduces wrinkles and fine lines
  • Improves skin firmness and elasticity
  • Accelerates wound healing
  • Reduces inflammation and oxidative damage
  • Promotes hair growth and thickness
  • Supports collagen and elastin production
  • May improve overall skin health and appearance
  • Resets aged fibroblast behavior
  • Anti-fibrotic — reduces scar tissue formation
  • Proposed enhancement of learning and memory consolidation
  • Neuroprotective via BDNF-TrkB pathway support
  • May improve mood and resilience to stress
  • Potential support for neurogenesis
  • Cognitive clarity and focus enhancement (reported anecdotally)
  • Explored for neurodegeneration and age-related cognitive decline
Side Effects
  • Temporary blue-green discoloration at injection site (from copper — harmless)
  • Post-injection sting (brief)
  • Skin irritation with topical use (rare)
  • Limited human safety data; largely anecdotal reports
  • Possible headache or mild overstimulation
  • Sleep disruption with late-day dosing
  • Unknown long-term safety profile
Stacks With